Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder.

By M. Kempton, Zainab Salvador, Marcus Munafò, John R. Geddes, A. Simmons, S. Frangou, Steven C. R. Williams. Archives of General Psychiatry, 2011

818 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The current state of the neurogenic theory of depression and anxiety. (2015, background): “This speculative theory initially rested several correlations between depression and AHN: depressed patients on average have smaller hippocampi (reviewed in [3]), elevation of glucocorticoids can trigger depression and impair AHN [4], and serotonergic agents used to treat depression can boost AHN [5”
Major depressive disorder (2016, methodology): “Volume group differences, effect sizes and confidence intervals of MDD compared with healthy controls are based on data from Kempton et al.(88), as are the comparisons of MDD”
Dopamine System Dysregulation in Major Depressive Disorders (2017, background): “Anatomically, MDD is associated with gray matter abnormalities and decreased volume in the mPFC (Price and Drevets, 2010; Kempton et al., 2011) as well as a reduction in the size of neurons and a loss of glia (Drevets et al.”